No Data
No Data
Mayne Pharma Group Limited's (ASX:MYX) Largest Shareholders Are Individual Investors With 38% Ownership, Institutions Own 33%
Mayne Pharma Group's Nextstellis Oral Contraceptive Receives Two Additional US Patents
Mayne Pharma Group (ASX:MYX) said that the US Patent and Trademark Office has granted patent numbers 11,964,055 and 11,957,694, providing additional protection to the Nextstellis oral contraceptive fo
Investors in Mayne Pharma Group (ASX:MYX) Have Seen Respectable Returns of 93% Over the Past Year
Analysts Expect Breakeven For Mayne Pharma Group Limited (ASX:MYX) Before Long
Mayne Pharma Upgraded to Buy From Hold by Canaccord Genuity
Mayne Pharma Upgraded to Buy From Hold by Canaccord Genuity
Mayne Pharma Price Target Raised 34% to A$7.38/Share by Wilsons
Mayne Pharma Price Target Raised 34% to A$7.38/Share by Wilsons
No Data